Results 101 to 110 of about 54,591 (139)

Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women. [PDF]

Breast Cancer Res Treat
Menes TS, Zippel D, Sklair-Levy M, Friedman E, Bernstein-Molho R, Faermann R, Madorsky Feldman D.   +6 more
europepmc   +1 more source

Case report: Emerging BRCA mutation confers benefit from olaparib after chemotherapy intolerance in advanced triple-negative breast cancer. [PDF]

Clin Case Rep
Shen XB, Wu JY, Li JY, Shao XY, Wang XJ.
europepmc   +1 more source

Cost-effectiveness analysis of olaparib maintenance therapy for BRCA mutation ovarian cancer in the public sector in Malaysia. [PDF]

PLoS One
Yong CM, Yehgambaram PAP, Lee SWH.
europepmc   +1 more source

The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians. [PDF]

Eur J Hum Genet
John AO, Singh A, Yadav P, Joel A, Thumaty DB, Fibi Ninan K, Georgy JT, Cherian AJ, Thomas S, Thomas A, Thomas V, Peedicayil A, Varghese D, Parthiban R, Ravichandran L, Johnson J, Thomas N, Yadav B, Patricia S, Selvamani B, Abraham D, Paul MJ, Chacko RT, Chapla A.   +23 more
europepmc   +1 more source

Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline <i>BRCA</i> Mutation. [PDF]

Cancers (Basel)
Lema L, Pérez-García JM, Blanch S, Balmaña J, García-Sáenz JÁ, Vegas EF, Jiménez B, de la Haba J, Campolier M, Shimizu E, Alcalá-López D, Sampayo-Cordero M, Cortés J, Llombart-Cussac A.   +13 more
europepmc   +1 more source

"There should be one spot that you can go:" BRCA mutation carriers' perspectives on cancer risk management and a hereditary cancer registry. [PDF]

J Community Genet
Hynes J, Dawson L, Seal M, Green J, Woods M, Etchegary H.   +5 more
europepmc   +1 more source

The Concept behind the Suitability of Menstrual Blood-Derived Stem Cells for the Management of Vaginal Atrophy among BRCA Mutation Carriers after RRSO. [PDF]

Int J Mol Sci
Cordeiro MR, Laranjeiro B, Figueiredo-Dias M.   +2 more
europepmc   +1 more source

Intrahepatic Cholangiocarcinoma with BRCA Mutation Achieved Pathological Complete Response after Neoadjuvant Gemcitabine, Cisplatin, and S-1 Therapy: A Case Report. [PDF]

Surg Case Rep
Morita Y, Oda K, Matsumoto A, Ida S, Kitajima R, Furuhashi S, Takeda M, Kikuchi H, Hiramatsu Y, Ito J, Chida T, Noritake H, Kawata K, Nagakura Y, Goto M, Baba S, Takeuchi H.   +16 more
europepmc   +1 more source

Short-term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in BRCA Mutation Carriers: A Nationwide Study in South Korea. [PDF]

Cancer Res Treat
Kim HY, Park J, Moon SJ, Jeong S, Hong JH, Lee JK, Cho GJ, Cho HW.   +7 more
europepmc   +1 more source